Five Stocks See Over 200% Gains, Summit Therapeutics Leads with 628% Increase
Five stocks, including Summit Therapeutics and Carvana Co., have experienced gains of over 200% this year, indicating their success in the market. Summit Therapeutics' ivonescrimab, a new cancer drug, has helped the company increase its value sevenfold, while Carvana's innovative approach to selling used cars online has attracted the attention of retail investors. These top-performing stocks offer potential for investors looking to capitalize on momentum. AppLovin, a software provider for mobile app developers, has seen a slight slowdown in growth, but analysts expect an increase in profits in the coming years. MicroStrategy, a software maker, is primarily used as a play on Bitcoin, with the company holding a significant amount of Bitcoin in its portfolio. Vistra Corp., a power generation company, has seen a rise in demand due to the increased need for electricity from artificial intelligence data centers. The author of the article admits to being too skeptical of big gainers in the past, with their recommended stocks gaining an average of 16.9% in 12 months, while the big winners they advised to avoid returned an average of 40.5%. They also disclose having a short position in MicroStrategy in a hedge fund they manage.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
New spot margin trading pair — HOLO/USDT!
FUN drops by 32.34% within 24 hours as it faces a steep short-term downturn
- FUN plunged 32.34% in 24 hours to $0.008938, marking a 541.8% monthly loss amid prolonged bearish trends. - Technical breakdowns, elevated selling pressure, and forced liquidations highlight deteriorating market sentiment and risk-off behavior. - Analysts identify key support below $0.0080 as critical, with bearish momentum confirmed by RSI (<30) and MACD indicators. - A trend-following backtest strategy proposes short positions based on technical signals to capitalize on extended downward trajectories.

OPEN has dropped by 189.51% within 24 hours during a significant market pullback
- OPEN's price plummeted 189.51% in 24 hours to $0.8907, marking its largest intraday decline in history. - The token fell 3793.63% over 7 days, matching identical monthly and yearly declines, signaling severe bearish momentum. - Technical analysts cite broken support levels and lack of bullish catalysts as key drivers of the sustained sell-off. - Absence of stabilizing volume or reversal patterns leaves the market vulnerable to further downward pressure.

New spot margin trading pair — LINEA/USDT!
Trending news
MoreCrypto prices
More








